Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1561-2021Class II

Remel Bile Esculin Azide Agar w/ 6mcg/ml Vancomycin, Product #R01186, 10/package -

Remel Inc / initiated 2021-04-22 / Terminated

Remel Inc began a recall of Remel Bile Esculin Azide Agar w/ 6mcg/ml Vancomycin, Product #R01186, 10/package - Product Usage: use in qualitative procedures as a screening method for... on . FDA classified it as Class II and gives the reason as "The media allows growth of E. faecalis ATCC 29212 with blackening of the media". As of , the recall status on record is Terminated.

Recall record

Recall number
Z-1561-2021
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Remel Inc
Product
Remel Bile Esculin Azide Agar w/ 6mcg/ml Vancomycin, Product #R01186, 10/package - Product Usage: use in qualitative procedures as a screening method for primary isolation and presumptive identification of vancomycin-resistance enterococci (VRE) from surveillance cultures.
Product code
JSO Culture Media, Antimicrobial Susceptibility Test, Excluding Mueller Hinton Agar
Reason for recall
The media allows growth of E. faecalis ATCC 29212 with blackening of the media.
FDA root cause
Mixed-up of materials/components
Action
The recalling firm issued customer letters dated 4/22/2021 via first class mail to its direct accounts.
Quantity in commerce
91/10-test units
Distribution
US Nationwide distribution in the states of AZ, CA, CO, CT, GA, IA, IL, IN, MA, MI, MN, MO, NC, ND, OH, OR, PA, SD, TN, TX, and VA. There was government distribution and no military or foreign distribution.
Product codes and lots
Lot #248035, Exp. 2021-04-27

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1561-2021
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1561-2021Class IITerminatedVoluntary: Firm initiated